Concepedia

Stephan G. Klinz

SG

Statistics

Publications

15

Citations

1.2K

H-Index

13

Active since

1991

Affiliations

Merrimack Pharmaceuticals (United States)(Current)

University of North Carolina at Chapel Hill

Roswell Park Comprehensive Cancer Center

Tufts University

Moffitt Cancer Center

Stephan G. Klinz is an author at Merrimack Pharmaceuticals (United States) specializing in oncology, pharmacology, and drug delivery.

ORCID

Publications per year

1991–2023

15

Publications

15

Neural cell adhesion molecules modulate tyrosine phosphorylation of tubulin in nerve growth cone membranes

Julie R. Atashi, Stephan G. Klinz, Christine A. Ingraham et al. · Neuron · 1992 · 195 citations

, , +16

Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion

Ashish Kalra, Jaeyeon Kim, Stephan G. Klinz et al. · Cancer Research · 2014 · 193 citations

, , +17

Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

Ramesh K. Ramanathan, Ronald L. Korn, Natarajan Raghunand et al. · Clinical Cancer Research · 2017 · 172 citations

, , +17

Ras‐dependent and ‐independent regulation of reactive oxygen species by mitogenic growth factors and TGF‐β1

Victor J. Thannickal, Regina M. Day, Stephan G. Klinz et al. · The FASEB Journal · 2000 · 145 citations

, , +17

An EGF receptor/Ral‐GTPase signaling cascade regulates c‐Src activity and substrate specificity

Takanori Goi, Michail Shipitsin, Zhimin Lu et al. · The EMBO Journal · 2000 · 126 citations · Full text

, , +13

1–5 of 15